SCHEMBL21779889

SCHEMBL21779889

CC(C)N1CC(N[C@@H](C)O)C1

nearest known ligand 0.30

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 2/20 0.30
CYP2D6 P10635 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26038002 1.00 HRH3 (0.30) HRH3CYP2D6
SCHEMBL22964700 0.83 HRH3 (0.40) HRH3CYP2D6
SCHEMBL21310140 0.83 HRH3 (0.40) HRH3CYP2D6
SCHEMBL15803259 0.80 CYP2D6 (0.32) HRH3CYP2D6
SCHEMBL24915995 0.77 KDM1A (0.42) HRH3CYP2D6
SCHEMBL26030835 0.76 HRH3 (0.33) HRH3CYP2D6
SCHEMBL21263638 0.75
SCHEMBL14751821 0.75
SCHEMBL21594467 0.75
SCHEMBL22489210 0.73 GAA (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3616753-A1 COMPOUNDS FOR MODULATING ADENOSINE A2B RECEPTOR AND ADENOSINE A2A RECEPTOR Corvus Pharmaceuticals, Inc. (US) 2020-03-04 EP disclosed